gvtcx

Palantir Foundry Transition & Exit Contract

NHS England Published 5 Jul 2023 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£24,925,000
Statuscomplete
Category (CPV) 72322000 +1 more
Deadline9 Jun 2023
Contract start12 Jun 2023
Contract end11 Jun 2024
Procedureselective
SME suitableNo
OCIDocds-b5fd17-7565b065-b946-4e1f-a012-8f8f0ff3dbb7

Award

SupplierValueDateStatus
PALANTIR TECHNOLOGIES UK LTD £24,925,000 8 Jun 2023 active

description

NHS England has put in place a new 12 month contract for the transition from the Palantir Foundry platform to the new Federated Data Platform & Associate Services (FDP-AS) supplier. This is to provide the smooth transition and exit service of critical products that were developed to respond to the Covid-19 pandemic (for Covid-19 and elective recovery purposes), to alternative provisions including the transition of products to the new FDP-AS supplier following completion of the procurement process and award to the FDP-AS supplier. This 12 month transition contract with Palantir will support the safe transition and exit from the incumbent supplier to the new FDP-AS supplier when it is awarded and established.

This contract notice references the future Federated Data Platform & Associated Services (FDP-AS) contract for context, however it should be noted it is a separate contract and procurement process.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
20 Jun 2023 Award (award) · 94e3bcb5-d82c-4bbf-a2aa-5fbb3ea9ca09-655065
5 Jul 2023 Award (award) · d1df0a11-60ad-4fa5-b375-986b972bc006-660046

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.